Patrik Renblad
Directeur Financier/CFO chez CANTARGIA AB
Postes actifs de Patrik Renblad
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CANTARGIA AB | Directeur Financier/CFO | 15/06/2023 | - |
Historique de carrière de Patrik Renblad
Anciens postes connus de Patrik Renblad
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SYNACT PHARMA AB | Directeur Financier/CFO | 07/01/2022 | 15/05/2023 |
| Corporate Officer/Principal | 01/08/2021 | 07/01/2022 | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - | - |
Formation de Patrik Renblad
| University of Lund | Graduate Degree |
Statistiques
Internationale
| Suède | 4 |
| Danemark | 2 |
Opérationnelle
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SYNACT PHARMA AB | Health Technology |
| CANTARGIA AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
- Bourse
- Insiders
- Patrik Renblad
- Expérience
